The Role of SGLT-2 Inhibitors as an Adjuvant to Insulin Therapy in Type-1 Diabetes Mellitus- Literature Review
Sultan Ali Alshehri, Sultan Abdulwahab M. Asiri, Aalaa Mohammad Algarni & Manal Mohammed Alamari · Journal of Pharmaceutical Research International · 2021
Background: Type 1 diabetes mellitus is the main risk factor for cardiovascular complications. Therefore, intensified insulin therapy might be needed to achieve better glycemic control in some patients. However, insulin therapy might lead to increase body weight and induce hypogl...
Open access
Research Article
10.9734/jpri/2021/v33i40B32295